Form 4: Blueprint Medicines EVP Tracey L. McCain Sells Shares to Cover Tax Obligations

Tracey L. McCain, EVP and Chief Legal Officer of Blueprint Medicines Corp, sold 5,262 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 5, 2025, Tracey L. McCain, EVP and Chief Legal Officer of Blueprint Medicines Corp, sold 5,262 shares of common stock.
• The shares were sold at a price of $88.8 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, McCain directly owns 66,583 shares of Blueprint Medicines Corp.
• The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's outlook on the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who sell shares to cover tax obligations related to stock-based compensation. It doesn't necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a routine transaction to cover tax obligations.

Key Dates